Compugen reported $352K in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Arca Biopharma 0 0 Mar/2025
aTyr Pharma USD 987.07K 797.07K Mar/2026
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Clal Biotechnology ILS -857K 1.42M Jun/2022
Compugen USD 352K 63.44M Mar/2026
Immunic 0 0 Mar/2025
Minerva Neurosciences -4.27M 26.79M Dec/2024
RedHill Biopharma USD 584K 0 Jun/2024
TherapeuticsMD USD 234K 79K Jun/2024